dsdsa

product

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

The organization keeps for the procedure concept "scientific administration, superior quality and effectiveness primacy, shopper supreme for 57773-65-6, Methotrexate Disodium Salt, Docetaxel Powder, We warmly welcome your participation according to mutual rewards during the around long term.
Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai Detail:

Product name Entecavir monohydrate
Synonyms 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
CAS No. 209216-23-9
Appearance White to off-white powder
Molecular Formula C12H15N5O3.H2O
Molecular Weight 295.30
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Entecavir monohydrate Cas: 209216-23-9

Items

Standard

Results

Appearance White to off-white powder Complies
Optical rotation +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) +27.0°
Identification A: By IR, To match with working standard Complies
B: By HPLC,retain time should match with working standard Complies
Water 5.8%—6.5% 6.1%
Isomer Single ≤0.1% 0.02%
Total ≤0.5% 0.02%
Related Substances Single impurity ≤0.1% 0.05%
Total impurities ≤0.3% 0.07%
Residue on ignition ≤0.1% 0.04%
Heavy metals £ 10ppm Complies
Residual  solvents Should be to match with the standard Complies
Assay ≥99.8% 99.9%
Conclusion:Complies to the in-house standards.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures


Related Product Guide:

Bear "Customer 1st, Good quality first" in mind, we work closely with our prospects and supply them with efficient and professional services for Professional China Anti Hepatitis C - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai , The product will supply to all over the world, such as: Estonia, India, Thailand, We have more than 200 staff including experienced managers, creative designers, sophisticated engineers and skilled workers. Through hard work of all employees for the past 20 years own company grew stronger and stronger. We always apply the "client first" principle. We also always fulfill all contracts to the point and therefore enjoy excellent reputation and trust among our customers. You are very welcome to personally visit our company.We hope to start a business partnership on the basis of mutual benefit and successful development . For more information please do no hesitate to contact us..
  • The sales person is professional and responsible, warm and polite, we had a pleasant conversation and no language barriers on communication.
    5 Stars By Megan from Hyderabad - 2018.11.04 10:32
    With a positive attitude of "regard the market, regard the custom, regard the science", the company works actively to do research and development. Hope we have a future business relationships and achieving mutual success.
    5 Stars By Belinda from Japan - 2018.06.30 17:29
    Write your message here and send it to us